|
|
.
See Category: Congenital malformations, deformations and chromosomal abnormalities
See Header: Congenital occlusion of ureter
ICD-10 (CM) Code and Descriptor
|
Q62.10 |
Congenital occlusion of ureter, unspecified
|
Q6210 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 20.14%
|
33.39%
|
17.73%
|
8.26%
|
3.96%
|
5.85%
|
3.44%
|
2.93%
|
0.69%
|
0.52%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for Q62.10*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
C1769
|
GUIDE WIRE |
27
|
42
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
26
|
26
|
|
J3010
|
FENTANYL CITRATE INJECTION |
24
|
44
|
|
Q9967
|
LOCM 300-399MG/ML IODINE,1ML |
22
|
1,230
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
21
|
21
|
|
J2250
|
INJ MIDAZOLAM HYDROCHLORIDE |
19
|
54
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
16
|
16
|
|
52332
|
CYSTOSCOPY AND TREATMENT |
14
|
14
|
|
J2405
|
ONDANSETRON HCL INJECTION |
13
|
50
|
|
75984
|
XRAY CONTROL CATHETER CHANGE |
13
|
14
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
12
|
302
|
|
80053
|
COMPREHEN METABOLIC PANEL |
12
|
12
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
12
|
85
|
|
C1729
|
CATH, DRAINAGE |
12
|
21
|
|
C1894
|
INTRO/SHEATH, NON-LASER |
11
|
12
|
|
C2617
|
STENT, NON-COR, TEM W/O DEL |
11
|
13
|
|
80048
|
METABOLIC PANEL TOTAL CA |
11
|
11
|
|
J7120
|
RINGERS LACTATE INFUSION |
11
|
11
|
|
J0696
|
CEFTRIAXONE SODIUM INJECTION |
10
|
60
|
|
50688
|
CHANGE OF URETER TUBE/STENT |
9
|
9
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
Q62.10 related to the following DRG Codes:
698-700
|
